Patent · US Expired

Non-infectious, replication defective, immunogenic HIV retrovirus-like particles produced from a recombinant HIV genome devoid of long terminal repeats

US5571712A · kind A · utility

12Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 6, 1994
Grant dateNov 5, 1996
Priority date
Expiry dateMay 6, 2014

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/924
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention is directed towards nucleic acid molecules capable of producing human immunodeficiency virus (HIV) retrovirus-like particles, which are non-infectious, replication defective, and immunogenic. Recombinant HIV genomes were generated that are devoid of long terminal repeats (LTRs) but contain a heterologous, inducible metallothionein promoter. Additional modifications have been made to the primer binding site, pol, vif, and env coding regions. Upon transfection into a suitable host these DNA molecules are capable of producing HIV retrovirus-like particles that lack genomic RNA. These non-infectious particles will provide suitable antigens for HIV diagnostic assays and immunogenic preparations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.